Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

Oliver Fetzer

Dr. Oliver Fetzer

Member of the Compensation Committee
Member of the Audit Committee
Since 2011, elected until 2022
1964, US citizen

Education MBA (Carnegie Mellon University, Pittsburgh, PA, USA), Ph.D. Pharmaceutical Sciences (Major: Medicinal Chemistry, University of South Carolina, USA)
Professional background
Since 2014 CEO Synthetic Genomics
2009 - 2014 Cerulean Pharma Inc., USA,
President and Chief Executive Officer, Member of the Board of Directors 
2007 - 2008 Sabbatical
2002 - 2007 Cubist Pharmaceuticals, USA, various management positions, including Senior Vice President, Corporate Development and Research and Development
1993 - 2002 The Boston Consulting Group, USA, between 2000 and 2002 Managing Director and Partner, Boston
Other activities
Synthetic Genomics2, member of the Board; Arena Pharmaceuticals1, member of the Board


1 public company
2 private company